INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4%
Thu, 24 Jan

INDOCO REMEDIES has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

INDOCO REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m2,7812,3562,62611.4%-5.6%
Other incomeRs m63672.7%3.6%
TurnoverRs m2,7872,3602,63111.5%-5.6%
ExpensesRs m2,3492,2382,3786.2%1.2%
Gross profitRs m432118248109.8%-42.7%
DepreciationRs m1731771770.5%2.5%
InterestRs m215037-25.7%75.5%
Profit before taxRs m243-10539-84.0%
TaxRs m17-27-14-185.7%
Profit after taxRs m227-7853-76.4%
Gross profit margin%15.55.09.4
Effective tax rate%6.926.0-36.9
Net profit margin%8.1-3.32.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 5.6% on a year-on-year (YoY) basis. The expenses were up by 1.2% YoY during the same period.
  • The company's operating profit declined by 42.7% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 9.4% in 3QFY19 as against 15.5% in 3QFY18.
  • Depreciation charges increased by 2.5% and finance costs increased by 75.5% YoY, respectively.
  • Other income increased by 3.6% YoY during the quarter.
  • Net profit for the quarter declined by 76.4% YoY. Net profit margins during the quarter declined from 8.1% in 3QFY18 to 2.0% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 11.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 6.2% QoQ during the same period.
  • The company's operating profit increased by 109.8% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 9.4% in 3QFY19 as against 5.0% in 2QFY18.
  • Net profit for the quarter increased by 168.5% QoQ, while net profit margins increased from -3.3% in 2QFY18 to 2.0% in 3QFY19.

To see how INDOCO REMEDIES has performed over the last eight quarters, please visit here.

INDOCO REMEDIES Share Price Performance

Over the last one year, INDOCO REMEDIES share price has moved up from Rs 298.1 to Rs 200.6, registering a Loss of Rs 97.5 or around 32.7%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,090.6 (up 0.2%). Over the last one year it has moved down from 15,142.6 to 14,090.6, a gain of 1,052 points (down 6.9%).

Overall, the S&P BSE SENSEX is up 0.2% over the year.

Current Valuations

At the current price of Rs 200.6, the price to earnings (P/E) ratio of INDOCO REMEDIES stands at 306.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.8 times.

Equitymaster requests your view! Post a comment on "INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4%". Click here!

  

Related Views on News

INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1% (Quarterly Result Update)

Nov 5, 2019 | Updated on Nov 5, 2019

For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries?(Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

My Best Trading Recommendation of the Year

Nov 22, 2019

My short-term views on the two assets, I'm most bullish on.

How We Made 12.68% in One Overnight Trade(The 5 Minute Wrapup)

Nov 25, 2019

This one trade had my subscribers laughing all the way to the bank.

How to Take Out Money from the Trading Terminal and Put it in to Your Pocket(Profit Hunter)

Nov 22, 2019

Here's a simple way to move money out of your trading terminal and into your pocket.

Two Trends to Look at as Sensex Crosses 41,000 Levels(Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Dec 5, 2019 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - NALWA SONS INV COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS